Inventor
GUZ NATHAN
US11 patents
⚠️ This page may combine multiple inventors who share the name “GUZ NATHAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
EXELIXIS INC
9 patentsUS10501418B2Dec 10, 2019
Crystalline solid forms of N-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-N′-(4-fluorophenyl) cyclopropane-1,1-dicarboxamide, processes for making, and methods of use
EXELIXIS INC12 citations91
US11724986B2Aug 15, 2023
Crystalline solid forms of N-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-N'-(4-fluorophenyl) cyclopropane-1,1-dicarboxamide, processes for making, and methods of use
EXELIXIS INC6 citations84
US10851061B2Dec 1, 2020
Crystalline solid forms of N-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-N′-(4-fluorophenyl) cyclopropane-1,1-dicarboxamide, processes for making, and methods of use
EXELIXIS INC8 citations82
US11760726B2Sep 19, 2023
Crystalline solid forms of N-{4-[(6,7-Dimethoxyquinolin-4-yl)oxy]phenyl} -n'-(4-fluorophenyl) cyclopropane-1,1-dicarboxamide, processes for making, and methods of use
EXELIXIS INC2 citations71
US10239858B2Mar 26, 2019
Process for making compounds for use in the treatment of cancer
EXELIXIS INC3 citations71
US9771347B2Sep 26, 2017
Process for making compounds for use in the treatment of cancer
EXELIXIS INC3 citations71
US12486233B2Dec 2, 2025
Crystalline Solid forms of N-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-N′-(4-fluorophenyl) cyclopropane-1,1-dicarboxamide, processes for making, and methods of use
EXELIXIS INC0 citations61
US11414396B2Aug 16, 2022
Process for making compounds for use in the treatment of cancer
EXELIXIS INC0 citations61
US10793541B2Oct 6, 2020
Process for making compounds for use in the treatment of cancer
EXELIXIS INC0 citations50
GLOBAL BLOOD THERAPEUTICS INC
2 patentsUS10077249B2Sep 18, 2018
Process for synthesizing 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)-pyridin-3-yl)methoxy)benzaldehyde
GLOBAL BLOOD THERAPEUTICS INC24 citations91
US10577345B2Mar 3, 2020
Process for synthesizing 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)-pyridin-3-yl)methoxy)benzaldehyde
GLOBAL BLOOD THERAPEUTICS INC12 citations83